Related Experiment Video
Updated: Feb 22, 2026

Project-Based Learning Guidelines for Health Sciences Students: An Analysis with Data Mining and Qualitative Techniques
Published on: December 9, 2022
A Pilot Project for Clinical Pharmacy Services in a Clinic for Children With Medical Complexity
Insights
Clinical pharmacy services in a pediatric complex care clinic identified approximately one drug therapy problem per patient. Pharmacist involvement is crucial for managing medication needs and ensuring continuity of care.
Area of Science:
- Pediatric healthcare
- Clinical pharmacy
- Complex care medicine
Background:
- Children with medical complexity often have significant drug-related needs.
- Managing polypharmacy in this population presents unique challenges.
- The role of clinical pharmacists in specialized pediatric clinics is not fully characterized.
Purpose of the Study:
- To evaluate the impact of clinical pharmacy services in a pediatric complex care clinic.
- To identify and characterize the drug-related needs of these children.
- To define and develop the pharmacist's role within the clinic setting.
Main Methods:
- A prospective descriptive study was conducted over 11 weeks.
- A clinical pharmacist actively participated in clinic visits.
- Data collected included patient characteristics, workload, and drug therapy problems.
Main Results:
- A pharmacist attended 46 visits with 43 patients, identifying 42 drug therapy problems (35 actual, 7 potential).
- The average rate was approximately one drug therapy problem per patient.
- Common issues included incorrect dosage, untreated conditions, potential drug interactions, and adverse effects.
Conclusions:
- Children with medical complexity face a high risk of drug therapy problems.
- Integrating a clinical pharmacist into the clinic is beneficial for identifying, preventing, and resolving medication issues.
- Pharmacist presence supports continuity of care for this vulnerable patient group.
Objective:
The primary objective of the project was to assess the impact of clinical pharmacy services in a clinic for children with medical complexity. Secondary objectives were to identify and characterize the drug-related needs of these patients and to describe and develop the role of a pharmacist in the clinic.
Methods:
This was a prospective descriptive study in which a clinical pharmacist staffed the clinic for children with medical complexity for 11 weeks, from January to March 2011. This allowed for the collection of baseline data, such as patient characteristics and measurements of pharmacist workload and assessment (eg, types of drug therapy problems, medication reconciliation, medication teaching).
Results:
A pharmacist participated in 46 clinic visits with 43 patients, identifying a total of 42 drug therapy problems. Of the 42 problems, 35 actual and 7 potential drug problems were identified, resulting in approximately 1 problem per patient. The most common actual problems included "dose too small" (37.1%) and "patient requires a medication for untreated condition" (20%). Common potential problems included "drug interactions" (43%) and "adverse effects" (57%).
Conclusions:
The pilot study demonstrates that children with medical complexity are at high risk for drug therapy problems and the presence of a clinic pharmacist is beneficial in the identification, prevention, and resolution of drug therapy problems, while helping ensure continuity of care in this population.
More Related Videos
04:53A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
07:31Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Distribution
Primary Healthcare Services
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
Preclinical Development: Overview